EurekAlert!, a service of AAAS
Home About us
Advanced Search
2-Sep-2014 00:18
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Bioinformatics

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 701-724 out of 724.

<< < 24 | 25 | 26 | 27 | 28 | 29

Public Release: 18-Sep-2012
The 2013 HFSP Nakasone Award goes to Stephen Quake of Stanford University
The Human Frontier Science Program Organization (HFSPO) is pleased to announce that the 2013 HFSP Nakasone Award has been conferred upon Stephen Quake of Stanford University for his pioneering inventions and discoveries that made innovative physical techniques available for biology and that are revolutionizing biophysics, biological automation, genome analysis, and personalized medicine.
The Human Frontier Science Program Organization

Contact: Guntram Bauer
communications@hfsp.org
Human Frontier Science Program

Public Release: 18-Sep-2012
BGI Tech develops whole exome sequencing analysis of FFPE DNA samples to boost biomedicine
BGI Tech Solutions Co., Ltd., a subsidiary company of BGI, announced today that they have achieved whole exome sequencing analysis of total degraded DNA as low as 200 ng from formalin fixed paraffin embedded samples.

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen

Public Release: 17-Sep-2012
Proceedings of the National Academy of Sciences
New research presents most extensive pictures ever of an organism's DNA mutation processes
Biologists and informaticists at Indiana University have produced one of the most extensive pictures ever of mutation processes in the DNA sequence of an organism, elucidating important new evolutionary information about the molecular nature of mutations and how fast those heritable changes occur.
US Army Research Office

Contact: Steve Chaplin
stjchap@iu.edu
812-856-1896
Indiana University

Public Release: 17-Sep-2012
Proceedings of the National Academy of Sciences
Blue Brain Project accurately predicts connections between neurons
In a landmark paper, published the week of Sept. 17 in PNAS, the EPFL's Blue Brain Project has identified key principles that determine synapse-scale connectivity by virtually reconstructing a cortical microcircuit and comparing it to a mammalian sample. These principles now make it possible to predict the locations of synapses in the neocortex.

Contact: Lionel Pousaz
lionel.pousaz@epfl.ch
Ecole Polytechnique Fédérale de Lausanne

Public Release: 14-Sep-2012
New NIH/NHGRI grants to harness nanoscale technologies to cut DNA sequencing costs
Grants of almost $19 million will help to develop technologies to dramatically reduce the cost of DNA sequencing, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, announced today.
NIH

Contact: Omar McCrimmon
mccrimmono@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute

Public Release: 13-Sep-2012
BMC Evolutionary Biology
Study of giant viruses shakes up tree of life
A new study of giant viruses supports the idea that viruses are ancient living organisms and not inanimate molecular remnants run amok, as some scientists have argued. The study reshapes the universal family tree, adding a fourth major branch to the three that most scientists agree represent the fundamental domains of life.
National Science Foundation

Contact: Diana Yates
diya@illinois.edu
217-333-5802
University of Illinois at Urbana-Champaign

Public Release: 13-Sep-2012
Cell
Gladstone scientists map the genomic blueprint of the heart
Scientists at the Gladstone Institutes have revealed the precise order and timing of hundreds of genetic "switches" required to construct a fully functional heart from embryonic heart cells -- providing new clues into the genetic basis for some forms of congenital heart disease.
NIH/Heart, Lung and Blood Institute, AHA, DeGeorge Charitable Trust, Younger Foundation, Roddenberry Foundation

Contact: Anne Holden
anne.holden@gladstone.ucsf.edu
415-734-2534
Gladstone Institutes

Public Release: 12-Sep-2012
Journal of Clinical Investigation
Weizmann Institute's mathematical model may lead to safer chemotherapy
The study explains why certain patients develop severe infections after chemotherapy and points to ways of averting this side-effect.

Contact: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science

Public Release: 9-Sep-2012
Mucosal Immunology
Uncovering the genome's regulatory code
A new, automated method for mapping protein-DNA interactions may lead to advances in personalized medicine.

Contact: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science

Public Release: 6-Sep-2012
2 pioneering plant genomics efforts given a funding boost by National Science Foundation
With research in plant biology "at a tipping point," in the words of a leading investigator, two pathbreaking efforts by scientists interested in making comparisons across and within sequenced plant genomes -- called Gramene and Plant Reactome -- have been given a significant funding boost and vote of confidence from the National Science Foundation.
National Science Foundation, National Institutes of Health

Contact: Peter Tarr
tarr@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory

Public Release: 6-Sep-2012
PLOS ONE
Storm of 'awakened' transposons may cause brain-cell pathologies in ALS, other illnesses
A team of neuroscientists and informatics experts at Cold Spring Harbor Laboratory reports important progress in an effort to understand the relationship between transposons – sequences of DNA that can jump around within the genome, potentially causing great damage – and mechanisms involved in serious neurodegenerative disorders including ALS, FTLD (frontotemporal lobar degeneration) and Alzheimer's disease.
National Institutes of Health, Dart Llc

Contact: Peter Tarr
tarr@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory

Public Release: 6-Sep-2012
Genome Research
Human genome far more active than thought
The GENCODE Consortium has found 50 percent more genes than previously thought. Among their discoveries, the team describe more than 10,000 novel genes, identify genes that have 'died' and others that are being resurrected.
National Institutes of Health, Wellcome Trust

Contact: Aileen Sheehy
press.office@sanger.ac.uk
0044-012-234-96928
Wellcome Trust Sanger Institute

Public Release: 5-Sep-2012
Grant funds West Coast Metabolomics Center
With a $9.3 million start-up grant from the National Institutes of Health, UC Davis plans to open the West Coast Metabolomics Center, a high-tech consortium of research and service laboratories that will help scientists better understand and develop more effective treatments for complex diseases like diabetes, cancer and atherosclerosis.
National Institutes of Health

Contact: Andy Fell
ahfell@ucdavis.edu
530-752-4533
University of California - Davis

Public Release: 5-Sep-2012
MycoKeys
DNA sequences need quality time too - guidelines for quality control published
DNA sequence data have become an indispensable source of information in biology, finding diverse uses such as molecular species identification and the exploration of biodiversity in complex environments like soil and seawater. Many research programs enabled by such molecular data would have seemed impossible just a few years ago, and the unparalleled resolution obtained through DNA sequences adds further to their attractiveness in biological research.

Contact: Dr. Henrik Nilsson
henrik.nilsson@bioenv.gu.se
46-317-862-623
Pensoft Publishers

Public Release: 5-Sep-2012
Nature
In massive genome analysis ENCODE data suggests 'gene' redefinition
As part of a huge collaborative effort called ENCODE (Encyclopedia of DNA Elements), a research team at CSHL has analyzed all the RNA messages, called transcripts, produced within human cells. They show that three-quarters of the genome is capable of being transcribed, indicating that nearly all of our genome is dynamic and active. This raises exciting new possibilities for research into complex genetic diseases.
NIH/National Human Genome Research Institute

Contact: Edward Brydon
ebrydon@cshl.edu
516-367-6822
Cold Spring Harbor Laboratory

Public Release: 5-Sep-2012
Nature
UMASS Medical School faculty annotate human genome for ENCODE project
The first comprehensive decoding and annotation of the human genome is being published today by the ENCyclopedia Of DNA Elements (ENCODE) project, an international consortium of scientists from 32 institutions, including the University of Massachusetts Medical School. The groundbreaking ENCODE discovery appears in a set of 30 papers in Nature, Genome Research and Genome Biology.
NIH/National Human Genome Research Institute

Contact: Jim Fessenden
james.fessenden@umassmed.edu
508-856-2000
University of Massachusetts Medical School

Public Release: 5-Sep-2012
Nature
Huge human gene study includes Penn State University research
The first integrated understanding of how the human genome functions will be published this week -- the triumphant result of a collaborative five-year project called ENCODE, involving more than 440 researchers working in 32 labs worldwide. Penn State's contribution involves using the new ENCODE data to help explain how genetic variants that do not affect the structure of encoded proteins could affect a person's susceptibility to disease.
NIH/National Human Genome Research Institute, National Science Foundation

Contact: Barbara K. Kennedy
science@psu.edu
814-863-4682
Penn State

Public Release: 5-Sep-2012
Nature
Fast forward for biomedical research: ENCODE scraps the junk
An international team of researchers has revealed that much of what has been called 'junk DNA' in the human genome is actually a massive control panel with millions of switches regulating the activity of our genes. Discovered by hundreds of scientists working on the ENCODE Project, the new information is so comprehensive and complex that it has given rise to a new publishing model.
NIH/National Human Genome Research Institute

Contact: Mary Todd Bergman
contactpress@ebi.ac.uk
44-122-349-4665
European Molecular Biology Laboratory - European Bioinformatics Institute

Public Release: 5-Sep-2012
Genome Research
The ENCODE Project publishes new genomic insights in special issue of Genome Research
Genome Research publishes online and in print today a special issue dedicated to The ENCODE (ENCyclopedia Of DNA Elements) Project, whose goal is to characterize all functional elements in the human genome. The entire issue will be freely available online on Sept. 6 to coordinate with additional ENCODE Consortium publications in Nature, Genome Biology, and other journals.

Contact: Peggy Calicchia
calicchi@cshl.edu
516-422-4012
Cold Spring Harbor Laboratory

Public Release: 4-Sep-2012
Arteriosclerosis, Thrombosis and Vascular Biology
Vitamin D supplements do not improve cholesterol as previous research suggested
A team of scientists from Rockefeller University has shown that, at least in the short term, cholesterol levels did not improve when volunteers with vitamin D deficiency received mega-doses of vitamin D.
National Institutes of Health

Contact: Joseph Bonner
bonnerj@rockefeller.edu
212-327-8998
Rockefeller University

Public Release: 4-Sep-2012
Eurofins MWG Operon reinforces NGS capability with Illumina HiSeq 2500 and Illumina MiSeq
Eurofins MWG Operon, one of the pioneers and key providers of next generation sequencing (NGS), has added an Illumina HiSeq 2500 and an Illumina MiSeq sequencer to its fleet of NGS sequencers.

Contact: Dr. Georg Gradl
georggradl@eurofins.com
49-809-282-89945
Eurofins Genomics

Public Release: 4-Sep-2012
PLOS ONE
Study points to new target for cancers resistant to Iressa and Herceptin
A more-sensitive method to analyze protein interactions has uncovered a new way that cancer cells may use the cell-surface molecule HER3 to drive tumor progression following treatment with HER1 and HER2 inhibitors. This study shows that HER3 could be up to 10 times more effective than HER2, the target for Herceptin, in recruiting the proteins that drive the rapid proliferation, enhanced survival and distant spread of cancer.
National Institutes of Health, Cancer Research Foundation, Illinois Department of Public Health

Contact: John Easton
john.easton@uchospitals.edu
773-795-5225
University of Chicago Medical Center

Public Release: 3-Sep-2012
EMBO Journal
Anchoring proteins influence glucose metabolism and insulin release
Scientists from the United States and Sweden have discovered a new control point that could be important as a drug target for the treatment of diabetes and other metabolic diseases.

Contact: Barry Whyte
communications@embo.org
0049-622-188-91108
EMBO

Public Release: 3-Sep-2012
Proceedings of the National Academy of Sciences
Mass spec makes the clinical grade
A new mass spectrometry-based test identifies proteins from blood with as much accuracy and sensitivity as the antibody-based tests used clinically, researchers report this week in Proceedings of the National Academy of Sciences Early Edition online. The head-to-head comparison using blood samples from cancer patients measured biomarkers, proteins whose presence identifies a disease or condition. The technique should be able to speed up development of protein-specific diagnostic tests and treatment.
National Institutes of Health, Department of Energy

Contact: Mary Beckman
mary.beckman@pnnl.gov
509-375-3688
DOE/Pacific Northwest National Laboratory

Showing releases 701-724 out of 724.

<< < 24 | 25 | 26 | 27 | 28 | 29